| |
| |
|
| Insider
Information: |
Evanson Jeff |
| Relationship: |
|
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
808,459 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,592,047 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
808,459 |
|
|
| Total
Value |
$4,592,047 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Outlook Therapeutics Inc |
OTLK |
|
2024-03-07 |
808,459 |
2020-03-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OTLK |
Outlook Therapeutics Inc |
CHIEF COMMERCIAL OFFICER |
• – – |
2024-03-07 |
4 |
B |
$0.42 |
$26,243 |
D/D |
62,484 |
808,459 |
0.01 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Chief Commercial Officer |
• – – |
2023-01-20 |
4 |
S |
$1.11 |
$296,370 |
D/D |
(267,000) |
745,975 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Chief Commercial Officer |
• – – |
2023-01-19 |
4 |
S |
$1.22 |
$125,971 |
D/D |
(103,255) |
1,012,975 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Chief Commercial Officer |
• – – |
2023-01-18 |
4 |
S |
$1.25 |
$42,173 |
D/D |
(33,738) |
1,116,230 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Chief Commercial Officer |
• – – |
2023-01-17 |
4 |
S |
$1.31 |
$35,582 |
D/D |
(27,162) |
1,149,968 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-12-03 |
4 |
B |
$1.34 |
$47,168 |
D/D |
35,200 |
1,177,130 |
2.74 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-02-23 |
4 |
S |
$2.09 |
$17,861 |
D/D |
(8,554) |
1,141,930 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-02-12 |
4 |
S |
$2.55 |
$145,281 |
D/D |
(56,973) |
1,150,484 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Chief Commercial Officer |
• – – |
2020-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,207,457 |
1,207,457 |
0 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
